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Background: The ‘FRIENDS for life’ program (FRIENDS) is a 10-session cognitive behavioral therapy (CBT) pro-
gram used for prevention and treatment of youth anxiety. There is discussion about whether FRIENDS is best
applied as prevention or as treatment. Methods: We compared FRIENDS delivered in schools as targeted pre-
vention to a previous specialist mental health clinic trial. The targeted prevention sample (N = 82;
Mage = 11.6 years, SD = 2.1; 75.0% girls) was identified and recruited by school nurses in collaboration with a
community psychologist. The clinical sample (N = 88, Mage = 11.7 years, SD = 2.1; 54.5% girls) was recruited
for a randomized controlled trial from community child- and adolescent psychiatric outpatient clinics and was
diagnosed with anxiety disorders. Results: Both samples showed significantly reduced anxiety symptoms from
baseline to postintervention, with medium mean effect sizes across raters (youths and parents) and timepoints
(post; 12-months follow-up). Baseline youth-reported anxiety symptom levels were similar between the sam-
ples, whereas parent-reported youth anxiety was higher in the clinical sample. Conclusions: The study suggests
that self-reported anxiety levels may not differ between youth recruited in schools and in clinic settings. The
results indicate promising results of the FRIENDS program when delivered in schools by less specialized health




 The FRIENDS for life program is effective in reducing anxiety symptoms, but it is unclear whether the pro-
gramworks best as prevention or as clinical treatment
What is new?
 School nurses, assisted by a community psychologist, can identify youth with similar levels of anxiety prob-
lems as a clinical sample of youth with anxiety diagnoses
• School-based targeted prevention may increase access to evidence-based intervention for youth with anxi-
ety problems
What is significant for clinical practice?
 The FRIENDS for life program showed similar and medium effect outcomes on anxiety, depression, and con-
duct problems both when delivered as targeted prevention in schools and as treatment in mental health
clinics.
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Introduction
Anxiety problems are prevalent among youth and may
negatively affect quality of life, school attendance, as well
as academic and social functioning (Cummings, Capor-
ino, & Kendall, 2014). Youth with anxiety disorders show
increased risk of later mood disorders, conduct prob-
lems, substance abuse, suicide ideation, and attempts,
and of unemployment and higher use of medical services
(Kendall et al., 2010; Rapee et al., 2005; Sareen, Houla-
han, Cox, & Asmundson, 2005). For these reasons, it is
important to prevent that youth with elevated anxiety
symptoms move on to fully develop anxiety disorders
and to provide effective treatment for youth who
have developed anxiety disorders. Prevention can be uni-
versal (i.e., addressing total populations) or targeted
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(i.e., addressing at-risk populations or persons with
mild-to-moderate symptom levels; Gullotta, 2015).
Meta-analyses have found group-based cognitive behav-
ioral treatment (CBT) programs to be effective for both
targeted prevention and treatment of anxiety in youth
(James et al., 2013; Lawrence, Rooke, & Creswell, 2017;
Neil & Christensen, 2009; Werner-Seidler, Perry, Calear,
Newby, & Christensen, 2017). However, many youths
with anxiety problems are not identified for targeted pre-
vention or remain symptomatic following CBT (James
et al., 2013). The field lacks knowledge about how to
identify youth with anxiety symptoms to offer targeted
prevention and to prevent youth from developing clinical
anxiety diagnoses.
Several CBT programs for targeted prevention and
treatment for anxiety in youth exist (James et al., 2013;
Neil & Christensen, 2009). In the current study, we used
the FRIENDS program, due to its’ evidence as an effec-
tive anxiety reduction group-based program (Barrett,
2004, 2008). FRIENDS is usually delivered over a 10-
week period with weekly sessions, where youth (aged 7–
15 years) may learn strategies to manage and reduce
their anxiety. Structured activities including role-play,
group discussions, and homework are applied to assist
youth to challenge their unhelpful cognitions and to per-
form exposure exercises. In a meta-analysis of anxiety
prevention programs, Fisak, Richard, and Mann (2011)
found FRIENDS to be more effective for anxiety reduc-
tion than other CBT programs. The initial evidence base
for FRIENDS included several trials from Paula Barrett’s
group, documenting anxiety reduction following the pro-
gram used as universal and targeted prevention, as well
as clinical treatment (e.g., Barrett, Dadds, & Rapee,
1996; Barrett, Duffy, Dadds, & Rapee, 2001; Barrett,
Shortt, Fox, & Wescombe, 2001; Lock & Barrett, 2003;
Lowry-Webster, Barrett, & Lock, 2003). Briesch, Hager-
moser Sanetti, and Briesch (2010) evaluated the evi-
dence for FRIENDS across universal prevention studies
(n = 8), targeted prevention (n = 3), and treatment stud-
ies (n = 3). Effect sizes (Cohen’s d) ranged from 0.16 to
1.00 and were higher for clinical studies with anxiety
disorders (ES = 0.84) than for targeted prevention stud-
ies (ES = 0.44) and universal prevention studies
(ES = 0.24).
To the best of our knowledge, previous studies of the
FRIENDS program are either designed as universal or
targeted prevention, or as treatment studies, and no
study to date has directly compared the two delivery
forms. This is unfortunate, as there is uncertainty as to
whether FRIENDS is more effective as a treatment pro-
gram than as a targeted prevention program (Barrett,
Cooper, Stallard, Zeggio, & Gallegos-Guajardo, 2017;
Maggin & Johnson, 2014). Furthermore, anxiety studies
using CBT protocols outside university settings and out-
side the country in which the protocol was developed
have been criticized for failure to benchmark the CBT
protocol across settings within the country the protocol
is being implemented (Jonsson, Thastum, Arendt, &
Juul-Sorensen, 2015). To address this gap, we com-
pared FRIENDS delivered as a group-based targeted pre-
vention program in schools and FRIENDS delivered to a
clinical sample, that is, groups of youth diagnosed with
anxiety disorders in community clinics, in the same geo-
graphical region of Norway. Our purpose was to bench-
mark both the baseline symptom levels of participants
as well as the outcomes (i.e., pre-post changes) between
the two settings. Furthermore, such comparisons can
help shed a light on several feasibility features when
implementing FRIENDS; such as how to identify youth
who need intervention and how setting and health care
profession factors may influence outcomes.
We have three main aims. Our first aim is to compare
baseline symptom levels (i.e., anxiety, depression, and
conduct problems) between the targeted prevention
school sample and the clinical sample. We added con-
duct problems as there is high comorbidity between
internalizing and externalizing symptoms in children
(e.g., Kendall et al., 2010). Furthermore, the symptom
profiles, in terms of externalizing and internalizing
symptoms, may be different in schools and clinical set-
tings, that is, in terms of which children are identified as
needing intervention. Examining whether there are sig-
nificant differences in symptom severity between the
samples will provide important information when bench-
marking FRIENDS in Norway, and shed light on the
extent to which health professionals in schools versus
specialist clinics deliver CBT to youth with substantially
different symptom levels. We expect the school sample
recruited for targeted prevention to have lower symptom
levels than the clinical sample, as the intake criteria for
mental health clinics is moderate to severe symptoms
(Norwegian Health Directorate, 2019).
Our second aim is to examine symptom changes from
baseline to post-treatment, and 3-month and 12-month
follow-up within the targeted prevention school sample,
to provide initial evidence for FRIENDS as targeted pre-
vention in Norway. We expect significant symptom
reduction from baseline to follow-up, based on previous
prevention trials (e.g., Barrett & Turner, 2001; Lowry-
Webster, Barrett, & Lock, 2003). The main outcomes in
the clinical sample were significant reductions in anxiety
and depression both based on youth- and parent-report
from baseline to post-treatment and have been
described in detail elsewhere (Wergeland et al., 2014).
Our final aim is to benchmark the outcomes of the tar-
geted prevention school sample against outcomes from
the clinical sample. In addition to the different recruit-
ment procedures, important differences between the set-
tings are assumed to influence the outcomes of the
program. For example, group leaders often differ
between schools and clinics—with primarily health
workers and school personnel without extensive CBT or
mental health training in schools, and clinical psycholo-
gists with extensive therapy training in specialist mental
health clinics. Furthermore, parent involvement is often
more extensive in clinical settings. Whereas parents may
be involved in separate parent meetings both in schools
and in clinics, parents are most often also involved in
joint parent–youth sessions in clinical settings. The
effects of FRIENDS delivered to anxious youths in differ-
ent setting within the same geographical area can bring
important knowledge about changes in youth anxiety
after targeted prevention compared to changes in youth
anxiety due to specialized mental health treatment.
Thus, we address the need for further examining the
effects of targeted prevention in school settings, and the
potential of reaching youth with anxiety problems at an
earlier (i.e., pre-clinical) stage. Based on previous find-
ings of larger effects of CBT anxiety programs when
applied in clinical samples compared to school samples
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(Briesch et al., 2010), we expect smaller effects of CBT in
the school sample compared to the clinical sample.
Methods
We compared the FRIENDS program delivered in two different
studies. Following a clinical randomized controlled trial for
youth with anxiety disorders (Wergeland et al., 2014), herein
referred to as the specialist clinical sample, we conducted a tar-
geted prevention open evaluation, herein called the targeted
prevention sample.
Sample and procedures
Targeted prevention sample. The targeted prevention
school sample comprised 82 youth aged 8 to 16 years (M
age = 11.6 years, SD = 2.1; 75.0% girls) who received the 10
session FRIENDS program during school hours. Each 90-min
group-session was administered on a weekly basis. If impair-
ment due to anxiety symptoms was identified during regular
routinemeetings with the school nurses and/or an intakemeet-
ing with a local community psychologist, caregivers were con-
tacted and informed about FRIENDS and the ongoing study.
Youths considered for inclusion were invited to a meeting with
their caregivers, the school nurse, and the community psychol-
ogist. Information about the study was given, and a joint deci-
sion was made as to whether the intervention was appropriate
for the individual youth, before informed consent was signed.
Youth were allocated into groups of maximum eight partici-
pants, with all groups led by two group leaders. Group leaders
were one community psychologist, one family therapist, and six
school nurses. Group leaders had on average 11 years of experi-
ence working with youth. All received two days of training in
FRIENDS and had delivered the intervention to 2–7 groups
using the same manual prior to participating in this study. All
received between 6 and 10 hr of supervision over the course of
each 10-session group, delivered by a psychologist experienced
with FRIENDS. The groups were conducted in eight different
public schools (four primary (<13 years) and four secondary
(>13 years), and one group was conducted at a youth health
center. All groups were planned and organized to avoid exam
periods. Transport to the group sessions for participants was
provided if needed. Breakfast was served at morning sessions.
All schools were in the samemedium-sized municipality close to
Norway’s second largest city. The sociodemographic data for the
area are representative of Norway (Statistics Norway, 2019).
There were no dropouts from the program.
Specialist clinic sample. The specialist clinic sample is the
group CBT (GCBT) arm of a randomized controlled trial for
youth anxiety disorders (Wergeland et al., 2014). The sample
comprised 88 youth aged 8–16 years (Mage = 11.7 years,
SD = 2.1; 54.5% girls) who received FRIENDS delivered in com-
munity child and adolescent mental health clinics. The clinical
sample was recruited among regular referrals to seven public
mental health clinics. Inclusion criteria were a primary diagno-
sis of separation anxiety disorder (33.0%), social phobia
(46.5%), or generalized anxiety disorder (20.5%), with a mean
clinical severity rating of the primary anxiety disorder on a 0–8
scale of 6.9 (SD = 1.2) on the Anxiety Disorders Interview
Schedule—Child and Parent versions (ADIS-C/P; Silverman &
Albano, 1996). Youth were allocated into groups of maximum
six participants, with all groups led by two group leaders. Group
leaders were nine clinical psychologist, five clinical pedagogues
(special educators with additional clinical training), and one
social worker. Group leaders had on average 12 years of experi-
ence working with youth. All therapists attended a two-day
workshop on CBT and childhood anxiety disorders, a two-day
FRIENDS workshop, and treated two pilot cases approved by
FRIENDS trainers before study start. For further details of the
clinic sample, see Wergeland et al. (2014).
The procedures for both samples were approved by the Regio-
nal Board for Medical and Health Research Ethics. All parents
and children above 12 years provided informed written consent.
Children aged 11 years or younger provided informed verbal
assent.
The FRIENDSmanual
The FRIENDS for life manual (Barrett, 2004, 2008) was used as
the intervention (4th edition, a translated version approved by
the developer). The manual addresses cognitive, physiological,
and behavioral components that interact in the development
and maintenance of anxiety. The FRIENDS acronym describes
the main features of the program: emotional awareness (Feel-
ings), emotion regulation (Relax), cognitive restructuring (Inner
helpful thoughts), exposure and problem solving (Explore solu-
tions and coping step plans), rewards (Now you can reward
yourself), and practice (Don’t forget to practice), with a positive
focus (Smile and stay calm). There are two separate versions of
the program according to developmental level (child version: 7–
12 years and adolescent version: 12–15 years). In both settings,
parents were invited to two parent evenings in which psychoed-
ucation about child anxiety and parental management strate-
gies were presented.
Measures
To evaluate the outcomes in the two settings, we included the
same measures of anxiety symptoms, depressive symptoms,
and conduct problem symptoms in both settings. Measures of
depressive symptoms were included because (a) there is often
high comorbidity between anxiety and depression; (b) interven-
tions for anxiety potentially also are helpful in reducing depres-
sive symptoms; and (c) anxiety often precedes comorbid
depressive disorders (Bienvenu & Ginsburg, 2007; Flannery-
Schroeder, 2006). Conduct problems were included to examine
whether anxiety interventions also reduce symptoms beyond
internalizing problems and whether this differed between the
school and clinic setting.
The Spence Children’s Anxiety Scale (SCAS; Spence, 1998)
child and parent version was used to measure youth anxiety
symptoms. The SCAS parent version comprises 38 items and
the SCAS child version comprises 45 items (including 8 ‘filler’
items with positive descriptions, e.g, ‘I like myself’). All items are
rated on a 4-point Likert scale from 0 (never) to 3 (always) with
higher scores indicating more anxiety. SCAS has demonstrated
test–retest reliability, concurrent validity, and excellent internal
consistency (Spence, 1998; Spence, Barrett, & Turner, 2003).
In the current study, inter-item reliabilities for the school and
clinical samples, respectively, were a = .95 and a = .88 for
youth-report, and a = .91 and a = .86 for parent-report.
The Short Moods and Feelings Questionnaire (SMFQ; Angold
et al., 1995) child and parent version was used to measure
youth depressive symptoms. SMFQ comprises 13 items rated
on a 3-point Likert scale from 0 (not true) to 2 (true) with higher
scores indicating more depressive symptoms. SMFQ has
demonstrated test–retest reliability, concurrent validity, and
excellent internal consistency (Angold et al., 1995; Kuo et al.,
2005; Sharp, Goodyer, & Croudace, 2006). In the current study,
inter-item reliabilities for the school and clinical samples,
respectively, were a = .94 and a = .89 for youth-report, and
a = .86 and a = .88 for parent-report.
The Strengths and Difficulties Questionnaire (SDQ; Goodman,
2001) child and parent version conduct problems subscale was
used to measure youth conduct problems. The SDQ conduct
subscale comprises five items rated from 0 (not true) to 2 (cer-
tainly true) with higher scores indicative of more significant
problems. The SDQ has demonstrated adequate test–retest reli-
ability, concurrent validity, and internal consistency (Goodman,
2001; Goodman & Scott, 1999). In the current study, inter-item
reliabilities for the SDQ in the school and clinic samples, respec-
tively, were a = .83 and a = .75 for youth-report, and a = .91
and a = .82 for parent-report.
Data analytic plan
In the school sample, 40.2% of youth and 74.4% of parents were
lost between post-treatment and 3-month follow-up. At 12-
month follow-up, these numbers had increased to 59.8% of
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youth and 80.5% of parents. In the clinic sample, 10.2%
dropped out during treatment and did not complete post-treat-
ment assessments, and a further 6.3% were lost to 12-month
follow-up. In both samples, Little’s missing completely at ran-
dom test indicated data were missing completely at random. To
retain as much data as possible, missing data were accommo-
dated using full information maximum likelihood (FIML) miss-
ing data methodology in Mplus (Wothke, 2000).
Since participants were treated in groups, analyses were
specified to account for the existence of possible clustering
effects in outcome variables in Mplus due to the clustering of
patients within groups (Muthen & Muthen, 2011). Latent
growth curve modeling (LGM), a structural equation modeling
technique, was used separately on the outcome measures to
model treatment response in symptoms over time, at the group
and individual level, with random intercepts and slope values.
In a latent growth curve model, the results indicate the effect of
the independent variable on the slope or rate of symptom
change during the treatment and follow-up periods. At post-
treatment, with two measurement points, this is considered a
difference score model (Duncan, Duncan, & Strycker, 2006).
There was no 3-month follow-up assessment in the clinical
sample. We calculated effect sizes using Cohen’s d ([M1  M2/
SDpooled]) using the following criteria: 0.20 = small,
0.50 = medium, and 0.80 = large (Cohen, 1992).
Results
Preliminary analyses
Due to the high level of missing data in the school sample
at follow-up, we first examined whether there were sig-
nificant differences at baseline within the school sample
between participants with complete pre-post data from
both youth and parents, and participants with missing
post-treatment data. We did this separately for each
measure, and no significant differences in baseline
symptoms were found (all p > .387).
Second, we examined differences between the school
sample and the clinic sample in baseline background
and symptom variables. There were significantly more
girls in the school sample (v2 = 8.247, p < .05). Within
the school sample, there were no significant gender dif-
ferences on any of the symptom variables. The same
applied within the clinic sample, except for youth-re-
ported depression, which was higher for girls (t = 3.107,
p < .05). There were no age differences between the sam-
ples. Only three of the participants in the school sample
(3.7%) reported to have received previous mental health
treatment.
Differences in baseline scores between the school
sample and the clinical sample
See Table 1 for baseline scores and effect size differences
between the school sample and the clinical sample. For
youth-report, there were no significant differences
between the school sample and the clinic sample on any
symptom scale. For parent-report, there was a signifi-
cant difference for anxiety symptoms, with the clinic
sample scoring higher. There was no significant differ-
ence between the school and the clinic sample for
depressive symptoms or conduct problems.
Symptom change from pre-intervention to 12-
month follow-up in the school sample
See Table 2 for overview of symptom changes from pre-
treatment to 12-month follow-up. For anxiety symp-
toms, there was a significant reduction from pre- to
post-treatment for youth- and parent-report. There was
no significant reduction from post-treatment to 3-month
follow-up. However, there was a significant reduction in
parent-report symptoms, but not youth-report (p = .07),
from 3- to 12-month follow-up. The reduction from base-
line to 12-month follow-up represents a small effect for
youth-report and a medium effect for parent-report (see
Figure 1).
For depressive symptoms, there was a significant
reduction from pre- to post-treatment for youth- and
parent-report. There was no significant reduction from
post-treatment to 3-month follow-up, or from 3 to 12-
month follow-up. The reduction from baseline to 12-
month follow-up represents a small effect for youth-re-
port and amedium effect for parent-report (see Figure 2).
For conduct problems (SDQ), there was no significant
changes for youth-report, or for parent-report from post-
treatment to 3-month follow-up. For parent-report,
there was a significant reduction from pre- to post-treat-
ment, and from 3-month to 12-month follow-up. The
reduction from baseline to 12-month follow-up repre-
sents a small effect for youth-report and a large effect for
parent-report (see Figure 3).
Differences in effect
Effect sizes were calculated from pre-post and from pre-
12-month follow-up for all measures and informants in
both samples. Effect size differences ranged from small
to large within both samples, across measures, raters,
and timepoints (see Figures 1–3). Across informants and
samples, the highest effects were evident for anxiety
symptoms (M d = 0.70), followed by depressive symp-
toms (M d = 0.53) and conduct problems (M d = 0.45).
Effect sizes were on average higher from pre-12-months
follow-up (M d = 0.56) than from pre-post (M d = 0.44),
and higher for parent-report (Md = 0.77) than for youth-
report (M d = 0.35). Finally, the average effect sizes were
practically the same in the school sample (M d = 0.57)
and in the clinic sample (Md = 0.55) and both were med-
ium.
Discussion
We compared the FRIENDS program delivered in schools
as targeted prevention and in community clinics as
treatment for youths with anxiety diagnoses. We found
only partial support for our expectation that baseline
symptoms would be higher in the clinical sample than
the school sample. Only parent-reported anxiety symp-
toms (for youth) were significantly higher in the clinical
sample. We found no difference between youths’ self-re-
ported symptoms on any symptom scale. This may
reflect the fact that parents most often initiate referral in
clinical samples, whereas youths in the school sample
were targeted and recruited by school nurses. With a few
exceptions, parents had not initiated clinical referral for
youths in the school sample, which may help explain
why they reported their child’s level of anxiety less severe
than parents in the clinical sample. However, the fact
that youth reported comparable levels of symptoms in
the two settings indicates that a substantial proportion
of youths in the targeted prevention sample may experi-
ence clinical levels of anxiety. This was surprising, given
that only three participants reported to have received
previous mental health services. It is possible that the
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school-based intervention reached youths who experi-
ence anxiety symptoms, with parents less aware of the
youths’ symptom levels. Alternatively, parents may (mis)
interpret youths’ anxiety symptoms as conduct prob-
lems, as indicated by the observed reduction in conduct
problems in the school sample. A review study identified
that the time span from onset of anxiety disorders to the
initiation of treatment ranges from 9 to 23 years (Jones,
2013). A more recent review study identified that limited
access to mental health services for youth is a consistent
problem and that mental health services should be reor-
ganized to focus on earlier identification of problems and
prevention (Fusar-Poli, 2019). In light of such calls, our
findings point to schools as a potentially useful arena for
such preventive interventions.
Alternatively, in the school sample, the anxiety prob-
lems may have affected the youth’s functioning at home
less than in school, making the parents less aware of the
youth’s anxiety symptoms. This indicates that interven-
tions in clinical and in school settings may reach differ-
ent groups of youth—but that these youths not
necessarily differ with regard to level of distress caused
by the anxiety symptoms. This could be examined in
future studies by including assessment of functional
impairment due to anxiety symptoms in school samples
versus clinic samples of anxious youths.
Our expectation that symptoms of anxiety, depres-
sion, and conduct problems would be reduced after par-
ticipating in FRIENDS in the school setting was largely
supported, although improvements were not significant
for all raters at all time points. Overall, however, the find-
ings provide further support for FRIENDS as a promising
intervention for targeted anxiety prevention in schools,
which has also been shown previously (e.g., Barrett &
Table 1. Symptom scores for 82 youth receiving CBT anxiety targeted prevention in schools compared to 88 youth receiving CBT anxiety
treatment in community clinics
Measure and time
Youth self-report Parent report
School Clinical d School Clinical d
SCAS
Baseline 32.1 (19.8) 36.6 (17.2) 0.23 22.9 (12.6) 34.9 (11.0)** 1.01
Post 25.8 (15.6) 27.7 (14.2) 0.13 19.5 (11.3) 26.7 (11.7)** 0.63
3-months f-upa 28.1 (15.9) – – 20.0 (7.8) – –
12-months f-upb 26.4 (14.5) 24.0 (19.0) 0.14 15.3 (6.1) 22.6 (14.0) 0.68
SMFQ
Baseline 8.7 (7.3) 7.5 (5.6) 0.18 6.7 (4.9) 7.5 (5.3) 0.16
Post 7.2 (6.4) 5.8 (5.4) 0.24 4.8 (4.2) 5.1 (5.1) 0.06
3-months f-upa 6.7 (7.0) – – 5.3 (4.1) – –
12-months f-upb 7.2 (6.9) 5.2 (5.8) 0.31 3.4 (3.3) 4.1 (4.1) 0.19
SDQ conduct
Baseline 6.3 (3.3) 6.2 (2.7) 0.03 6.0 (3.1) 5.5 (2.9) 0.17
Post 6.4 (3.4) 5.6 (3.6) 0.23 4.9 (3.0) 4.9 (3.4) 0.00
3-months f-upa 6.0 (3.5) – – 4.1 (2.7) – –
12-months f-upb 5.5 (2.7) 5.5 (3.8) 0.00 3.1 (2.4) 4.6 (3.4)* 0.51
d, effect size; f-up, follow-up; SCAS, Spence Children’s Anxiety Scale; SDQ, Strengths and Difficulties Questionnaire; SMFQ, Short Moods
and Feelings Questionnaire.
aNo data from clinical sample.
b12-month follow-up data only available for n = 46 in school sample.
*Difference between school and clinical parent sample is significant at the p < .05 level.
**Difference between school and clinical parent sample is significant at the p < .001 level.
Table 2. Symptom change from pre- to post-treatment, 3- and 12-month follow-up for 82 youth receiving school-based targeted preven-
tion for anxiety
Post-treatment 3-month follow-up 12-month follow-up
Changea 95% CI p Changeb 95% CI p Changec 95% CI p
SCAS
Youth 5.8 [8.5,3.0] <.001 1 [0.5, 2.6] .190 1.6 [0.1, 3.3] .070
Parent 2.7 [4.6,0.8] <.010 0.3 [3.2, 2.6] .849 4.3 [6.5,2.2] <.001
SMFQ
Youth 1.5 [2.5,0.5] .006 0.3 [2.1, 1.4] .721 1.15 [0.5, 2.8] .170
Parent 1.9 [2.9,0.9] <.001 0.4 [2.3, 3.1] .781 1.6 [4.1, 1.0] .228
SDQ-Con
Youth 0.1 [0.5, 0.6] .789 0.3 [1.3, 0.8] .615 0.6 [0.7, 1.8] .353
Parent 1.1 [1.8,0.5] <.001 0.4 [1.4, 0.5] .347 1.2 [1.9,0.5] <.001
CI, confidence interval; SCAS, Spence Children’s Anxiety Scale; SDQ-Con, Strengths and Difficulties Questionnaire Conduct problems sub-
scale; SMFQ, Short Moods and Feelings Questionnaire.
aCompared to baseline.
bCompared to at post-treatment.
cCompared to at 3-month follow-up.
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Turner, 2001; Lock & Barrett, 2003; Lowry-Webster
et al., 2001, 2003; Stallard et al., 2014).
There was practically no difference in outcome effects
between the two samples. Compared to the therapists at
the mental health clinics, health nurses have limited
training in mental health interventions in general and in
delivering CBT programs in particular. Our results indi-
cate that targeted prevention with FRIENDS, given
supervision for group leaders, may be delivered by
health personnel not having specialized therapeutic or
previous CBT training.
The current study has several limitations. First, the
inclusion criteria in the school sample were not stan-
dardized, but based on the judgment of school nurses in
cooperation with a clinically trained community psychol-
ogist. Recruitment and inclusion were based on a shared
decision between the youth, parents, and school nurses
in collaboration with the community psychologist.
Although this inclusion strategy may challenge general-
izability of our results and prevents us from calculating
a response rate, this pragmatic procedure reflects com-
mon practice in school health services and thus points
to the ecological validity of our findings. Second, many
participants were lost from postintervention to 12-
month follow-up in the school sample. Although these
data were missing completely at random and there were
no baseline symptom differences between participants
with and without follow-up data, the follow-up data
should be considered with caution. Third, we examined
several effects (i.e., two raters of three measures at two
time points), which increases the chance of misinterpret-
ing effects as nonrandom. However, the effect for youth-
rated depression symptoms at post-treatment is the only
reported effect that would not have passed a Bonferonni-
corrected p-level (i.e., .05/12 = .004). Fourth, the two
samples had different gender ratios. Although there were
no gender differences in baseline symptoms within the
school sample, the high ratio of girls in the school sample
may have influenced the self-reported symptom levels
toward higher scores for the school sample, and partly
explain the similarity in symptom levels between the two
samples. Finally, we had no control group for the school
sample and cannot rule out the possibility of symptom
changes caused by other factors than the intervention
(e.g., maturation).
In terms of implications for future research, the out-
comes from the school sample need to be examined in a
randomized controlled design. Deciding on control
groups in randomized trials is a thorny issue. Given the
considerable documentation to date that CBT is better
than waitlist, active control conditions may be most use-
ful to the field. Comparing the FRIENDSmanual to other
programs and/or examining various forms of delivery
(e.g., individual vs. group) could inform the optimal ways
to deliver CBT as prevention in schools. Furthermore,
studies are needed that more systematically register how
nurses assess youth anxiety problems, and the extent to
which nurses identify those youths whomost need inter-
ventions. Designs that examine various parent involve-
ment components in school settings are also indicated.
The main clinical implication from the current study
is that the FRIENDS program shows promising out-
comes when delivered as a group program by school
nurses for youth with anxiety. Furthermore, school
nurses seem able to identify youth who from their own
perspective show levels of anxiety symptoms comparable
to a clinic sample of youth diagnosed with anxiety disor-
ders. In our study, the school nurses obtained almost
just as good results when delivering the FRIENDS
Figure 1. Changes in youth- and parent-reported anxiety symp-
toms (SCAS) from baseline to 12-month follow-up for the
targeted prevention school sample and the clinical sample [Col-
our figure can be viewed at wileyonlinelibrary.com
Figure 2. Changes in youth- and parent-reported depression
symptoms (SMFQ) from baseline to 12-month follow-up for the
targeted prevention school sample and the clinical sample [Col-
our figure can be viewed at wileyonlinelibrary.com
Figure 3. Changes in youth- and parent-reported conduct prob-
lems (SDQ) from baseline to 12-month follow-up for the targeted
prevention school sample and the clinical sample [Colour figure
can be viewed at wileyonlinelibrary.com
© 2020 The Authors. Child and Adolescent Mental Health published by John Wiley & Sons Ltd on behalf of Association for Child and
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program as therapists working in community child and
adolescent mental health clinics. It is important to note
that the school nurses received supervision during inter-
vention delivery. A common criticism of prevention pro-
grams is that they are associated with small effect sizes
compared to control groups (Teubert & Pinquart, 2011).
However, it is important to keep in mind that in preven-
tion (as compared to treatment), even small effect sizes
are likely to be associated with meaningful improve-
ments, particularly at a population level. Therefore, even
a small effect size difference is likely to contribute to pre-
vent the onset of these disorders in youth. In this study,
both the school setting and the clinical setting showed
medium average effect size within each sample across
measures, raters, and timepoints, although parents in
the clinical setting had more extensive parental-involve-
ment. In conclusion, given appropriate training and ade-
quate supervision, school nurses should continue to
identify youth at risk for anxiety and offer group-based
CBT interventions.
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